Literature DB >> 10998698

Novel Drug Delivery Systems.

.   

Abstract

Interest in pain management is growing, with the emerging demand by our patients and colleagues, for pain relief. To meet that need, pharmaceutical and medical technology companies have provided the medical field with a variety of choices and options to deliver medication for pain control. Examination and review of the present systemic options are introduced. A more detailed look at the intrathecal route is necessary because of the tremendous potential for receptor-targeted drug delivery. The ability to treat nociceptive and neuropathic pain with drug-specific therapy makes this system all the more exciting. Because of this future, a wealth of new and old drugs are being found or reexamined for their use.

Entities:  

Year:  1999        PMID: 10998698     DOI: 10.1007/s11916-999-0084-z

Source DB:  PubMed          Journal:  Curr Rev Pain        ISSN: 1069-5850


  31 in total

1.  The effects of personal and environmental factors on health behaviors of older adults.

Authors:  L Seigley
Journal:  Nursingconnections       Date:  1998

2.  Octreotide: a potent new non-opiate analgesic for intrathecal infusion.

Authors:  Richard D Penn; Judith A Paice; Jeffrey S Kroin
Journal:  Pain       Date:  1992-04       Impact factor: 6.961

Review 3.  Novel routes of opioid administration.

Authors:  J M Alexander-Williams; D J Rowbotham
Journal:  Br J Anaesth       Date:  1998-07       Impact factor: 9.166

Review 4.  Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.

Authors:  W Jeal; P Benfield
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 5.  Clinical realities and economic considerations: patient selection in intrathecal therapy.

Authors:  E S Krames; K Olson
Journal:  J Pain Symptom Manage       Date:  1997-09       Impact factor: 3.612

Review 6.  Cancer pain management.

Authors:  E Bruera; P Lawlor
Journal:  Acta Anaesthesiol Scand       Date:  1997-01       Impact factor: 2.105

7.  In vitro and in vivo studies of subcutaneous hydromorphone implants designed for the treatment of cancer pain.

Authors:  G J Lesser; S A Grossman; K W Leong; H Lo; S Eller
Journal:  Pain       Date:  1996 May-Jun       Impact factor: 6.961

8.  The iontophoresis of fentanyl citrate in humans.

Authors:  M A Ashburn; J Streisand; J Zhang; G Love; M Rowin; S Niu; J K Kievit; J R Kroep; M J Mertens
Journal:  Anesthesiology       Date:  1995-05       Impact factor: 7.892

9.  Alternative intrathecal agents for the treatment of pain.

Authors:  S J Hassenbusch; J Garber; E Buchser; S Du Pen; P Nitescu
Journal:  Neuromodulation       Date:  1999-04

Review 10.  Pharmacological treatment of cancer pain: alternative routes of opioid administration.

Authors:  C Ripamonti; E Zecca; F De Conno
Journal:  Tumori       Date:  1998 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.